Sophia Koo, M.D.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals (NCT05210101) | Sophia Koo, M.D. | 2022-02-07 |
Track Sophia Koo, M.D. automatically
Every clearance here is in the API, with alerts when new ones post.